Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era

Methods. Between January 1995 and December 1999, 185 kidney transplants were performed with tacrolimus (TAC)-based immunosuppression including 120 African American (AA, 65%) and 65 Caucasian recipients (C, 35%). Mean follow-up was 34 months. The AA group was characterized by a higher incidence of re...

Full description

Saved in:
Bibliographic Details
Published in:Surgery 2001-10, Vol.130 (4), p.738-747
Main Authors: Hardinger, Karen L., Stratta, Robert J., Egidi, M.Francesca, Alloway, Rita R., Shokouh-Amiri, M.Hosein, Gaber, Lillian W., Grewal, Hani P., Honaker, Marsha R., Vera, Santiago, Gaber, A.Osama
Format: Article
Language:English
Subjects:
Adult
Aged
Black or African American
Black People
Cyclosporine - therapeutic use
Female
Graft Rejection - epidemiology
Graft Survival
Humans
Immunosuppressive Agents - therapeutic use
Kidney Diseases - etiology
Kidney Transplantation - adverse effects
Kidney Transplantation - mortality
Male
Middle Aged
Tacrolimus - therapeutic use
Transplantation, Homologous
White People
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods. Between January 1995 and December 1999, 185 kidney transplants were performed with tacrolimus (TAC)-based immunosuppression including 120 African American (AA, 65%) and 65 Caucasian recipients (C, 35%). Mean follow-up was 34 months. The AA group was characterized by a higher incidence of renal disease due to hypertension (72% AA vs 37% C, P
ISSN:0039-6060
1532-7361
DOI:10.1067/msy.2001.116922